Back to search

University of Patras

Η θρομβίνη και ο υποδοχέας της PAR-1, ως στόχοι για την ανάπτυξη νέων φαρμάκων στην αντιμετώπιση ασθενειών που σχετίζονται με την αγγειογένεση

Abstract

dc:description

Angiogenesis regulates many physiological and pathological processes, so it is of great interest to find out the mechanisms that are involved. Many studies support that thrombin and PAR-1 play pivotal role in angiogenesis. In the present study we found that SCH79797 and RWJ56110, two PAR-1 antagonists, suppressed angiogenesis in vivo in the chick chorioallantoic membrane model and in vitro in the Matrigel system. These inhibitory effects were dose-dependent and well correlated with the inhibitory effects of SCH79797 and RWJ56110 on primary endothelial cell proliferation, phosphorylation of Erk1/2 and on the initiation of apoptosis. Furthermore, we found that thrombin is a poor growth factor for human endothelial cells and its limited mitogenic effect is mediated indirectly by transactivation of epidermal growth factor receptor. On the other hand, it was demonstrated that thrombin was a potent anti-apoptotic factor for endothelial cells. Thrombin selectively promoted survival of serum-starved endothelial cells in a concentration-dependent manner. This effect of thrombin was largely independent of its catalytic activity and was mediated through interaction with ανβ3 integrin, while the involvement of protease-activated receptor-1 was limited.

Degree

thesis:*
Grantor dc:publisher
University of Patras
Year dc:date
2007

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Zania, Panagiota
  • Ζανιά, Παναγιώτα

Subjects

dc:subject × 16

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/25649

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Zania, Panagiota; Ζανιά, Παναγιώτα. Η θρομβίνη και ο υποδοχέας της PAR-1, ως στόχοι για την ανάπτυξη νέων φαρμάκων στην αντιμετώπιση ασθενειών που σχετίζονται με την αγγειογένεση. University of Patras, 2007. http://hdl.handle.net/10442/hedi/25649